Long-Term Safety of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis
Long-Term Safety of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis David T. Rubin 1, Bruce A. C. Cree 2, Douglas C. Wolf 3, Olga Alekseeva 4, Lorna Charles 5, AnnKatrin Petersen 5, James K. Sheffield 5, Chun-Yen Cheng 5, Jon V. Riolo 5, Diego Silva 5, Fred D. […]
Efficacy and Durability of Ozanimod by Baseline Endoscopic Disease Activity in Advanced Therapy–Naive Patients With Ulcerative Colitis
Efficacy and Durability of Ozanimod by Baseline Endoscopic Disease Activity in Advanced Therapy–Naive Patients With Ulcerative Colitis David T. Rubin 1, Britta Siegmund 2, Geert D’Haens 3, Peter Irving 4, Irina Blumenstein 5, Corey A. Siegel 6, Edward V. Loftus Jr 7, Douglas C. Wolf 8, Bincy Abraham 9, Freddy Caldera 10, Laurent Peyrin-Biroulet 11, […]
;
